NADPH oxidase genes expression in peripheral blood mononuclear cells (PBMC) in anti-TNF alpha-treated rheumatoid arthritis patients and its impact on type I interferon activity, clinical outcome and treatment response.
2018/31/N/NZ5/03023
Keywords
Descriptors
- NZ5_7: Leczenie chorób człowieka
- NZ5_3: Patogeneza chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Instytut Reumatologii im. prof. dr hab. med. Eleonory Reicher
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 16 – announced on 2018-09-14
- Amount awarded
- 207 260 PLN
- Project start date
- 2019-07-24
- Project end date
- 2023-07-23
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (2)
-
Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
- Authors:
- Tomasz Wysocki, Agnieszka Paradowska-Gorycka
- Academic press:
- International Journal of Molecular Sciences (year: 2022, volume: 23(4), pages: 2366), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/ijms23042366 – link to the publication
-
NADPH oxidase expression profile and PBMC immunophenotypic changes in anti-TNF-treated rheumatoid arthritis patients
- Authors:
- Tomasz Wysocki, Anna Wajda, Tomasz Kmiołek, Jakub Wroński, Magdalena Roszkowska, Marzena Olesińska, Agnieszka Paradowska-Gorycka
- Academic press:
- Clinical Immunology (year: 2025, volume: 271, pages: 110414), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.clim.2024.110414 – link to the publication